StephenKFieldMD

Pulmonology • Barnett, MO

Restrictive Lung Disease, Thoracic Oncology

Academic pulmonary, clinical Professor

Join to view full profile

Dr. Field is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Field's full profile

Already have an account?

Office
University of Calgary University Faculty Of Medicine
Health Science Centre 3330 Hospital Dr NW Calgary T2N 4N1
Barnett, MO 65011
Phone+1 403-220-8722

Summary

Dr. Stephen Field is a pulmonologist in Calgary, Alberta. He received his medical degree from McGill University Faculty of Medicine and has been in practice 41 years.

Education & Training

McGill University Faculty of MedicineClass of 1976, MDCM

Certifications & Licensure

American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Pulmonary Disease
Royal College of Physicians and Surgeons of CanadaInternal Medicine
Royal College of Physicians and Surgeons of CanadaRespiratory Medicine

Publications & Presentations

PubMed

4 citations
Disease burden in individuals with symptomatic undiagnosed asthma or COPD.
Fatmah F Alhabeeb, G A Whitmore, Katherine L Vandemheen, J Mark FitzGerald, Celine Bergeron
Respiratory Medicine. 2022-07-03
20 citations
Performance Characteristics of Spirometry With Negative Bronchodilator Response and Methacholine Challenge Testing and Implications for Asthma Diagnosis
Janannii Selvanathan, Shawn D. Aaron, Jenna Sykes, Katherine L. Vandemheen, J. Mark FitzGerald
Chest. 2020-04-13
21 citations
Population-Based Case-Finding to Identify Subjects with Undiagnosed Asthma or COPD
Matthew Preteroti, G. Alex Whitmore, Katherine L. Vandemheen, J. Mark FitzGerald, Catherine Lemière
The European Respiratory Journal. 2020-01-01

Journal Articles

Legionnaire’s Disease-results of a multicentre Canadian Study.
Marrie TJ, De Carolis E, Yu VL, Stout J, and the Canadian community-acquired pneumonia investigators- Duperval R, Field S, Louie T, Houston S, Gribble M, Williams K, N..., Can J Infect Dis 2003;14:154-8
Recommendations on the management of chronic bronchitis. A practical guide for Canadian physicians.
Balter MS, Hyland RH, Low DE, Renzi P, Braude AC, Cole PJ, Hodder RV, McCombs JS, Allard C, Braidy J, Brown NE, Duguid N, Field SK, et al., Supplement, CMAJ 1994; 151(10): 5-23
The antibiotic puzzle: guidelines for the family physician. A Prairie Consensus Conference.
Harding G, Field S, MacMahon R, Louie T and the Prairie Consensus Conference Group, Can J Infect Dis 1997;8 (supplement C):2-16
. Patient education in asthma: impact of nurse educators
Underwood MF, Revitt SG, Field SK, Cowie RL, Dis Manage Health Outcomes 1999;5:303-09
Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update
Mandell LA, Marrie TJ, Grossman RF, Chow AW, Hyland RH, Shafran SD, Field SK, La Forge J, Zhanel G, Rotstein C, Chan CKN, Low DE, McIvor RA, Bartlet..., Clin Infect Dis 2000; 31: 383-42
Summary of Canadian guidelines for the initial management of community-acquired pneumonia: an evidence based update
Mandell LA and the Canadian CAP working group Marrie TJ, Grossman RF, Chow AW, Hyland RH, Shafran SD, Field SK, La Forge J, Zhanel G, Rotstein C, Chan CKN, Low DE, Mc..., Can J Infect Dis 2000;11: 237-48
. Point of view. Gastroesophageal reflux and asthma
Field SK, Annals Royal College of Physicians and Surgeons of Canada 2000;33: 362-6
Summary of Canadian guidelines for the initial management of community-acquired pneumonia: an evidence based update
Mandell LA, Marrie TJ, Grossman RF, Chow AW, Hyland RH, Shafran SD, Field SK, La Forge J, Zhanel G, Rotstein C, Chan CKN, Low DE, McIvor RA, Bartlett JG, Campbell GD..., Can Respir J 2000;7: 371-82
Legionella-like and other amoebal pathogens as agents of community-acquired pneumonia.
Marrie TJ, Raoult D, La Scola B, Birtles RJ, de Carolis E; Canadian Community-Acquired Pneumonia Study Group-Duperval R, Field S, Louie T, Houston S, Gribble M, Will..., Emerg Infect Dis 2001;7:1026-9
The addition of salmeterol 50 mug bid to anticholinergic treatment in patients with COPD: A randomized, placebo controlled trial
Chapman KR. Arvidsson P. Chuchalin AG. Dhillon DP. Faurschou P. Goldstein RS. Kuipers AF. Acres J. Amer E. Balter M. Bishop G. Blackie S. Bouchard J. Chan C. Cou..., Can Respir J. 2002;9:178-85
Seroepidemiology of Coxiella burnetti infection and its frequency as a cause of community-acquired pneumonia.
. Marrie TJ, De Carolis E, Duperval R, Field S, Louie T, Houston S, Gribble M, Williams K, Nicolle L, et al., Can J Infect Dis 2002;13:164-66
How to recognize and treat reflux in patients with asthma
Field SK, Cowie RL, J Respir Dis 2003;24:152-157
Chlamydia species as a cause of community-acquied pneumonia in Canada.
Marrie TJ, Peeling RW, Reid T, De Carolis E and the Canadian Community-Acquired Pneumonia Investigators- Duperval R, Field S, Louie T, Houston S, ..., Eur Respir J 2003;21:779-84
A comparison of bacteremic pneumococcal pneumonia with nonbacteremic community-acquired pneumonia of any etiology- results from a Canadian multicentre study
Marrie TJ, Low DE, De Carolis E and the Canadian Community-Acquired Pneumonia Investigators Duperval R, Field S, Louie T, Houston S, Gribble M, Williams K, Nicolle L, ..., Can Respir J 2003;10:368-74
Resource use study in COPD (RUSIC): a prospective study to quantify the effects of COPD exacerbations on health care resource use among COPD patients.
Fitzgerald JM, Haddon JM, Bradley-Kennedy C, Kuramoto L, Ford GT, Arndt S, Axler J, Barclay S, Bartlett J, Bayly K, Bennett R, Bernstein I, Brankston E, Chapman K, ..., Can Respir J 2007;14:145-52
A randomized controlled trial to assess the efficacy of tiotropium in Canadian patients with chronic obstructive pulmonary disease
. Chan CKN, Maltais F, Sigouin, et al, Can Respir J 2007;14: 465-72
The assessment and treatment of drug-resistant tuberculosis
Field SK, Drug Benefit Trends 2009;21:246-60
Opinions differ by expertise in Mycobacterium avium complex disease
. Marras TK, Prevots DR, Jamieson FB, Winthrop KL, pulmonary MAC outcomes group: Aksamit TR, Catanzaro A, Cowie RL, Czaja CA, Daley CL, Fennelly KP, Field SK, Fisher D..., Annals ATS 2014 Jan;11(1):9-16
Chronic cough is predominantly a woman’s issue.
Field SK, Conley DP, Paramchuk L, Leigh R, Walker BL, Cowie RL, J Pulmonol, Respir Ther 2017;1:002
Diabetes Mellitus in Adult Patients with Active Tuberculosis in Canada: Prevalence, Presentation, and Treatment Outcomes
Barss L, Sabur N, Orlikow E, Phang S, Arget M, Jarand J, Field S, Ainslie M, Fisher D., CJRCCSM 2019;3(2):84-90 CJRCCSM 2019;3(2):84-90, 12/21/2018
Chronic refractory cough: what to do when inhalers, nasal sprays and pills don’t work
Field SK, CJRCCSM 2018 2018;2(4):194-199, 10/22/2018
Safety and efficacy of delamanid in the treatment of multidrug-resistant tuberculosis (MDR TB),
Field SK, Clinical Medicine Insights: Therapeutics 2013:5 137, 9/25/2013
Join now to see all

Books/Book Chapters

Canadian TB Standards, 6th edition.
Chapter: Nontuberculous mycobacteria
Cowie RL, Field SK, Fanning A. Nontuberculous mycobacteriaPublic Health Agency of Canada, OttawaEdition 6th,

Other

Editorial Consultant, Mycobacterial infections for the Physicians’ Information and Education Resource (PIER)
Field SK, acponline.org
Physicians’ Information and Education Resource (PIER) 2009-10